MX2016016800A - Metodos para el tratamiento del sobrepeso o la obesidad. - Google Patents

Metodos para el tratamiento del sobrepeso o la obesidad.

Info

Publication number
MX2016016800A
MX2016016800A MX2016016800A MX2016016800A MX2016016800A MX 2016016800 A MX2016016800 A MX 2016016800A MX 2016016800 A MX2016016800 A MX 2016016800A MX 2016016800 A MX2016016800 A MX 2016016800A MX 2016016800 A MX2016016800 A MX 2016016800A
Authority
MX
Mexico
Prior art keywords
obesity
methods
subject
treating overweight
treatment
Prior art date
Application number
MX2016016800A
Other languages
English (en)
Other versions
MX386595B (es
Inventor
Zohar Yishai
Sannino Alessandro
S Ron Eyal
Heshmati Hassan
Original Assignee
Gelesis Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gelesis Llc filed Critical Gelesis Llc
Publication of MX2016016800A publication Critical patent/MX2016016800A/es
Publication of MX386595B publication Critical patent/MX386595B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/738—Cross-linked polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invencion se relaciona con metodos de gestion de peso y tratamiento del sobrepeso o la obesidad y tratamiento o prevencion de diabetes en un sujeto que los necesite. En una modalidad, el metodo comprende los pasos de (a) administrar al sujeto por via oral de aproximadamente 0.7 g a aproximadamente 4 g de carboximetilcelulosa reticulada; y (b) administrar al sujeto por via oral al menos aproximadamente 100 ml de agua por gramo de carboximetilcelulosa reticulada. Los pasos (a) y (b) se realizan antes de o con al menos una comida al dia.
MX2016016800A 2014-06-20 2015-06-19 Métodos para el tratamiento del sobrepeso o la obesidad. MX386595B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462014926P 2014-06-20 2014-06-20
PCT/US2015/036654 WO2015196054A1 (en) 2014-06-20 2015-06-19 Methods for treating overweight or obesity

Publications (2)

Publication Number Publication Date
MX2016016800A true MX2016016800A (es) 2017-05-03
MX386595B MX386595B (es) 2025-03-19

Family

ID=54868671

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016016800A MX386595B (es) 2014-06-20 2015-06-19 Métodos para el tratamiento del sobrepeso o la obesidad.

Country Status (11)

Country Link
US (3) US9855294B2 (es)
EP (1) EP3157536B1 (es)
JP (1) JP6726109B2 (es)
KR (2) KR20170029432A (es)
CN (2) CN106470689A (es)
AU (1) AU2015276889B2 (es)
BR (1) BR112016029713A8 (es)
CA (1) CA2950482C (es)
MX (1) MX386595B (es)
RU (1) RU2696494C2 (es)
WO (1) WO2015196054A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010001629A (es) * 2007-08-10 2010-08-09 Alessandro Sannino Hidrogeles de polimero y metodos de preparacion de los mismos.
EP2717685B1 (en) 2011-06-07 2018-08-22 Gelesis LLC Method for producing hydrogels
CA2950482C (en) 2014-06-20 2022-12-06 Gelesis, Llc Methods for treating overweight or obesity
CA2974967C (en) 2015-01-29 2023-06-27 Gelesis Llc Method for producing hydrogels coupling high elastic modulus and absorbance
CA2987863A1 (en) 2015-06-01 2016-12-08 Xeno Biosciences Inc. Methods and compositions to modulate the gut microbiota and to manage weight
JP7132128B2 (ja) * 2016-04-25 2022-09-06 ジェレシス，エルエルシー 便秘の治療方法
EP3468670B1 (en) * 2016-06-10 2023-12-13 University of Copenhagen Predetermined diet for use in inducing weight loss and preventing weight gain
WO2017213961A1 (en) * 2016-06-10 2017-12-14 Gelesis Llc Methods of inducing weight loss, treating obesity and preventing weight gain
CN110520111B (zh) 2016-11-30 2023-12-19 塞诺生物科学股份有限公司 用以管理体重和调节肠道微生物群的药物制剂和方法
AU2018248418A1 (en) * 2017-04-05 2019-11-21 Gelesis, Llc Improved superabsorbent materials and methods of production thereof
AU2018251210B2 (en) * 2017-04-14 2025-01-23 Gelesis S.r.l. Compositions and methods for treating or preventing gut permeability-related disorders
US12110562B2 (en) 2017-06-01 2024-10-08 University Of Copenhagen Compositions and methods for predicting and promoting weight loss
US11925660B2 (en) 2018-08-10 2024-03-12 Simeon Investment, Inc. Treatment for obesity with superabsorbent materials
US12285738B2 (en) 2018-08-10 2025-04-29 Simeon Investment, Inc. Modulation of glucose bioaccessibility with superabsorbent materials
US11918602B2 (en) 2018-08-10 2024-03-05 Simeon Investment, Inc. Methods for reducing cholesterol with superabsorbent materials
WO2021067076A1 (en) * 2019-10-01 2021-04-08 Brillian Pharma Inc. Methods for treating or preventing obesity and body weight management
RU2749484C1 (ru) * 2020-06-18 2021-06-11 Федеральное государственное бюджетное образовательное учреждение высшего образования "Уральский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО УГМУ Минздрава России) Способ оценки массы тела человека
WO2022203606A1 (en) * 2021-03-23 2022-09-29 The Chloroplast Pte. Ltd. Superabsorbent hydrogels
US20250134923A1 (en) * 2021-09-09 2025-05-01 Junion Labs Pte. Ltd. Superabsorbent hydrogels with lipase inhibitor
CN114009797A (zh) * 2021-11-17 2022-02-08 上海市第十人民医院 一种减肥组合物及其制备方法和应用
CN114381014B (zh) * 2021-12-16 2023-02-17 佑道(天津)健康咨询有限公司 一种可生物降解的水凝胶及其应用
CN117179281A (zh) * 2022-01-28 2023-12-08 至睿生物(江苏)有限公司 一种用于体重控制的复合凝胶及其制备方法和应用
CN114702734A (zh) * 2022-04-08 2022-07-05 重庆师范大学 一种纤维素醚类凝胶及其制备方法和应用
CN116807980B (zh) * 2023-07-10 2024-11-05 橡果美健实业投资股份有限公司 用于肥胖干预的胃内占容水凝胶颗粒的制备方法及应用
CN117796533A (zh) * 2024-01-24 2024-04-02 纽湃腾（北京）医药科技有限公司 一种强效饱腹减肥水凝胶、组合物及其制备方法

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE212969C (es)
US3526048A (en) 1967-06-07 1970-09-01 Us Agriculture Cellulose fibers cross-linked and esterified with polycarboxylic acids
DD212969A1 (de) 1982-12-30 1984-08-29 Adw Inst Polymerenchemie Verfahren zur modifizierung von carboxymethylcellulose
JPS62141001A (ja) 1985-12-13 1987-06-24 Dai Ichi Kogyo Seiyaku Co Ltd 水不溶性のカルボキシアルキルセルロ−ス・アルカリ金属塩の製造方法
JPH01187048A (ja) 1988-01-18 1989-07-26 Dai Ichi Kogyo Seiyaku Co Ltd 糠漬け用組成物
US5137537A (en) 1989-11-07 1992-08-11 The Procter & Gamble Cellulose Company Absorbent structure containing individualized, polycarboxylic acid crosslinked wood pulp cellulose fibers
WO1991016057A1 (en) 1990-04-18 1991-10-31 University Of Utah COLONIC-TARGETED ORAL DRUG-DOSAGE FORMS BASED ON CROSSLINKED HYDROGELS CONTAINING AZOBONDS AND EXHIBITING pH-DEPENDENT SWELLING
GB9017800D0 (en) 1990-08-14 1990-09-26 Unilever Plc Moisture barrier and its preparation
US5247072A (en) 1991-10-25 1993-09-21 Kimberly-Clark Corporation Carboxyalkyl polysaccharides having improved absorbent properties and process for the preparation thereof
US5550189A (en) 1992-04-17 1996-08-27 Kimberly-Clark Corporation Modified polysaccharides having improved absorbent properties and process for the preparation thereof
SK281042B6 (sk) 1992-09-18 2000-11-07 Yamanouchi Pharmaceutical Co., Ltd Prípravok hydrogélového typu s ustáleným uvoľňovaním
JP3274550B2 (ja) 1993-08-03 2002-04-15 株式会社日本触媒 吸水材の製法
KR100391244B1 (ko) 1994-03-18 2003-12-01 더 프록터 앤드 갬블 캄파니 개별화된 폴리카복실산 가교결합 셀룰로즈섬유의 제조방법
AU3274895A (en) 1994-07-18 1996-02-16 Gel Sciences, Inc. Novel polymer gel networks and methods of use
BR9509869A (pt) 1994-12-09 1997-11-25 Procter & Gamble Composto absorvente e processo para produzir esse composto absorvente
US20010006677A1 (en) 1996-10-29 2001-07-05 Mcginity James W. Effervescence polymeric film drug delivery system
DE19654745C5 (de) 1996-12-30 2004-01-22 Lechner, M.D., Prof. Dr. Biologisch abbaubares Absorptionsmittel, dessen Herstellung und Verwendung
US6271278B1 (en) 1997-05-13 2001-08-07 Purdue Research Foundation Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties
AU3561697A (en) 1997-06-24 1999-01-04 Sca Molnlycke Ab Absorbent polymer material based on renewable starting materials
CO5070628A1 (es) 1997-11-25 2001-08-28 Kimberly Clark Co Espuma absorbente que comprende un polimero, el producto absorbente que la comprende y el proceso para su preparacion
AU1908500A (en) 1998-11-30 2000-06-19 Hercules Incorporated Controlled release carbohydrate embedded in a crosslinked polysaccharide
ATE483480T1 (de) 1998-12-16 2010-10-15 Tno Saure superabsorbierende polysaccharide
US6471824B1 (en) 1998-12-29 2002-10-29 Weyerhaeuser Company Carboxylated cellulosic fibers
US6867346B1 (en) 1999-09-21 2005-03-15 Weyerhaeuser Company Absorbent composite having fibrous bands
EP1134232A1 (en) 2000-03-16 2001-09-19 SCA Hygiene Products AB Polysaccharide-based superabsorbent film
RU2002133855A (ru) 2000-05-15 2004-06-27 Кимберли-Кларк Ворлдвайд, Инк. (Us) Полисахаридный абсорбент и способ его получения
US6472006B1 (en) 2001-04-05 2002-10-29 Kraft Foods Holdings, Inc. Oven-stable edible moisture barrier
DE10125599A1 (de) 2001-05-25 2002-11-28 Stockhausen Chem Fab Gmbh Superabsorber, Verfahren zu ihrer Herstellung und ihre Verwendung
EP1425320B1 (de) 2001-06-28 2006-09-20 Basf Aktiengesellschaft Saure hochquellfähige hydrogele
JP4132993B2 (ja) 2002-06-03 2008-08-13 住友精化株式会社 吸水性樹脂およびその製造方法
US7648619B2 (en) 2002-06-04 2010-01-19 Industrial Technology Research Hydrogel-driven micropump
US20040192582A1 (en) 2002-12-19 2004-09-30 Burnett Daniel R. Ingestible formulations for transient, noninvasive reduction of gastric volume
NL1023257C2 (nl) 2003-04-24 2004-10-27 Tno Vochtwerende bekledingslaag voor voedingsmiddelen.
WO2005036971A1 (en) 2003-10-16 2005-04-28 Techcom Group, Llc Reduced digestible carbohydrate food having reduced blood glucose response
US8128958B2 (en) 2003-11-10 2012-03-06 Astellas Pharma Inc. Sustained release pharmaceutical composition
US20050143571A1 (en) 2003-12-30 2005-06-30 Weyerhaeuser Company Method for forming individualized intrafiber crosslinked cellulosic fibers with improved brightness and color
KR100863870B1 (ko) 2004-06-21 2008-10-15 에보닉 스톡하우젠 게엠베하 수분 흡수성 다당류 및 이의 제조방법
WO2006061087A1 (en) 2004-12-08 2006-06-15 Unilever Plc Satiety enhancing food product and a method for manufacturing such
US20060142480A1 (en) 2004-12-29 2006-06-29 Mengkui Luo Method of making carboxyalkyl cellulose polymer network
US20060142478A1 (en) 2004-12-29 2006-06-29 Mengkui Luo Carboxyalkyl cellulose polymer network
ITTO20040918A1 (it) 2004-12-29 2005-03-29 Luigi Ambrosio Idrogel polimerici superassorbenti biodegradabili e procedimento per la loro preparazione
JP5638736B2 (ja) 2004-12-30 2014-12-10 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼーション 腸の健康を改善する方法および手段
CA2617051C (en) 2005-07-29 2013-12-17 Stichting Groningen Centre For Drug Research Ph-controlled pulsatile delivery system, methods for preparation and use thereof
JP2009531462A (ja) 2006-03-28 2009-09-03 ジェレシス， インク． 性能向上のためのポリマ材料と他の物質との併用
RU2008142840A (ru) 2006-03-30 2010-05-10 Джелесис, Инк. (Us) Сополимер стирола и малеинового ангидрида/кислоты (варианты), изделие на его основе, способ получения сополимера стирола и малеинового ангидрида/кислоты
AU2007233106A1 (en) 2006-03-30 2007-10-11 Exotech Bio Solutions Ltd. Styrene-maleic anhydride copolymers for bioapplications and their preparation
GB2445818B8 (en) 2006-09-15 2011-06-22 Japan Atomic Energy Agency Preparation of gels derived from carboxymethyl cellulose alkali metal salt
JP4288618B2 (ja) 2006-09-15 2009-07-01 独立行政法人 日本原子力研究開発機構 カルボキシメチルセルロースゲルの製造方法
US20080147026A1 (en) 2006-12-15 2008-06-19 Jian Qin Absorbent fiber with a low absorbent capacity and slow absorption rate
JP2008195649A (ja) 2007-02-13 2008-08-28 Daicel Chem Ind Ltd 害虫防除用ベイト剤及びその製造方法
CA2685568A1 (en) * 2007-05-02 2008-11-13 Dana-Farber Cancer Institute, Inc. Methods of treating diabetes using bad bh3 domain peptide
JP2008285611A (ja) 2007-05-18 2008-11-27 Daicel Chem Ind Ltd 架橋ゲルの製造方法及びその架橋ゲル
MX2010001629A (es) 2007-08-10 2010-08-09 Alessandro Sannino Hidrogeles de polimero y metodos de preparacion de los mismos.
US8039683B2 (en) 2007-10-15 2011-10-18 Kimberly-Clark Worldwide, Inc. Absorbent composites having improved fluid wicking and web integrity
US9345809B2 (en) 2007-11-28 2016-05-24 Fziomed, Inc. Carboxymethylcellulose polyethylene glycol compositions for medical uses
KR101932616B1 (ko) * 2008-11-18 2018-12-27 젤레시스 엘엘씨 체중 관리 및 혈당 조절 개선을 위한 방법 및 조성물
RU2441654C2 (ru) * 2010-02-17 2012-02-10 Лабораториос Баго С.А. Фармацевтическая композиция с активностью против ожирения, включающая премикс чистого орлистата, и способ ее изготовления
EP2717685B1 (en) 2011-06-07 2018-08-22 Gelesis LLC Method for producing hydrogels
CA2950482C (en) 2014-06-20 2022-12-06 Gelesis, Llc Methods for treating overweight or obesity
CA2974967C (en) 2015-01-29 2023-06-27 Gelesis Llc Method for producing hydrogels coupling high elastic modulus and absorbance
JP7132128B2 (ja) 2016-04-25 2022-09-06 ジェレシス，エルエルシー 便秘の治療方法

Also Published As

Publication number Publication date
US20180153925A1 (en) 2018-06-07
US11628184B2 (en) 2023-04-18
US20210260099A1 (en) 2021-08-26
MX386595B (es) 2025-03-19
RU2016148609A3 (es) 2019-01-17
CA2950482A1 (en) 2015-12-23
RU2696494C2 (ru) 2019-08-02
AU2015276889B2 (en) 2019-04-18
KR20230085212A (ko) 2023-06-13
KR20170029432A (ko) 2017-03-15
US9855294B2 (en) 2018-01-02
EP3157536B1 (en) 2026-03-18
CN115381850A (zh) 2022-11-25
US20150366898A1 (en) 2015-12-24
RU2016148609A (ru) 2018-07-20
CA2950482C (en) 2022-12-06
BR112016029713A2 (pt) 2017-08-22
EP3157536A4 (en) 2018-01-24
JP2017519751A (ja) 2017-07-20
US10953038B2 (en) 2021-03-23
JP6726109B2 (ja) 2020-07-22
AU2015276889A1 (en) 2016-11-24
WO2015196054A1 (en) 2015-12-23
EP3157536A1 (en) 2017-04-26
BR112016029713A8 (pt) 2021-07-20
CN106470689A (zh) 2017-03-01

Similar Documents

Publication Publication Date Title
MX2016016800A (es) Metodos para el tratamiento del sobrepeso o la obesidad.
CO2019001044A2 (es) Composición de cannabis
UA118025C2 (uk) Модулятор андрогенних рецепторів і його застосування
MX384234B (es) Uso de pridopidina para el tratamiento de enfermedad de huntington.
MX2015015228A (es) Sobetirome en el tratamiento de enfermedades de mielinizacion.
MX2019002265A (es) Uso de pridopidina para el tratamiento de la disminucion funcional.
MX2016010854A (es) Metodos para el tratamiento o la prevencion del asma mediante la administracion de un antagonista de il-4r.
MA34019B1 (fr) Aryltriazolone liée à un bis-aryle et son utilisation
MX380252B (es) Crenezumab para usarse en el tratamiento de enfermedad de alzheimer.
MX2015009963A (es) Metodos y composición farmacéutica para el tratamiento y la prevención de cardiomiopatía debido a falta de energía.
MX2017000627A (es) Metodos para tratar pacientes con hipercolesterolemia familiar heterocigota (hfhe).
MX377576B (es) Formulaciones de pridopidina de liberación modificada.
MX2015013948A (es) Composicion farmaceutica, metodos para tratamiento y sus usos.
UY35548A (es) Péptidos terapéuticos para el tratamiento de trastornos metabólicos.
MX2016013245A (es) Regimen de dosificacion de liberacion inmediata de moduladores s1p.
CL2017000050A1 (es) Terapia de combinación para el cáncer
ZA202301198B (en) Method of treating diseases
MX377438B (es) Administracion de tasimelteon en condiciones de ayuno.
MX392470B (es) Composición farmacéutica que comprende un péptido wt1 para el tratamiento o prevención de una enfermedad angiogénica.
MX2016011115A (es) Terapia inmunorreguladora contra autoinmunidad en diabetes tipo 1.
MX2017015424A (es) Nanoparticulas para su uso como vacuna terapeutica.
AR095594A1 (es) Métodos para tratar infecciones en pacientes con sobrepeso y obesos usando antibióticos
BR112016029437A2 (pt) métodos para tratamento e prevenção de doenças de instabilidade vascular
UY35890A (es) Uso de laquinimod para retrasar la progresión de la enfermedad de huntington
MX2016014755A (es) Moduladores de proteinas del choque termico 70 (hsp70) y metodos para fabricar y usar el mismo.